rubidium (82Rb) chloride

North America

Canada (0)
No result.
United States (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CARDIOGEN-82 N/A inj
Y
Rx
INJECTION
V09GX04
RUBY-FILL N/A sol
Y
Rx
iv
V09GX04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CARDIOGEN-82 N/A inj
19414/1
NDA
29-12-1989
RUBY-FILL N/A sol
202153/1
NDA
30-09-2016
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (0)
No result.
Belgium (0)
No result.
Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (0)
No result.
Malta (0)
No result.
Netherlands (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
RUBICARD 3 radionuclide generator
-
Rx
iv
V09GX04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
RUBICARD 3 radionuclide generator
RVG 121869
-
20-12-2019
Product
Pack
SPC
PIL
Company
RUBICARD 3 radionuclide generator
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Norway (0)
No result.
Poland (0)
No result.
Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (0)
No result.
Switzerland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
RUBY-FILL (RUBIDIUM RB-82 GENERATOR) 3.7 GBQ Generator
-
A
-
V09GX04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
RUBY-FILL (RUBIDIUM RB-82 GENERATOR) 3.7 GBQ Generator
65080 1
Hauptzulassung
18-12-2015
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.